3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
10
Carcinoma, Non-Small-Cell Lung
5
Neoplasms
3
Glioblastoma
3
Colorectal Neoplasms
3
Skin Neoplasms
2
Ovarian Neoplasms
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Hot Flashes
2
Vulvodynia
1
Thromboembolism
1
Severe Acute Respiratory Syndrome
1
Recurrence
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Hemorrhage
1
Pleural Effusion, Malignant
1
Platinum Resistant Ovarian Cancer
1
Parathyroid Neoplasms
1
Pancreatic Neoplasms
1
Pain, Postoperative
1
Neutropenia
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Myasthenia Gravis
1
Multiple Myeloma
1
Multiple Endocrine Neoplasia Type 1
1
Interventions
fludarabine phosphate
10
Whole-Body Irradiation
8
Peripheral Blood Stem Cell Transplantation
8
Cyclophosphamide
8
Busulfan
8
Mycophenolic Acid
7
Tacrolimus
6
Antilymphocyte Serum
6
Methotrexate
5
Cyclosporine
5
Melphalan
4
Etoposide
4
thymoglobulin
3
Sirolimus
3
Rituximab
3
Radiotherapy
3
Cord Blood Stem Cell Transplantation
3
fludarabine
2
Ondansetron
2
Granulocyte Colony-Stimulating Factor
2
Dexamethasone
2
Cytarabine
2
Cyclosporins
2
Carmustine
2
Calcium Dobesilate
2
Aprepitant
2
rasburicase
1
etoposide phosphate
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Pdgfra-Associated Chronic Eosinophilic Leukemia
×
Sodium Chloride
×
Clear all
No trials found.